January 27, 2024

Prospective Phase II Trial for Recurrent High-Grade Malignant Gliomas with Capacitive Coupled Low Radiofrequency (LRF) Deep Hyperthermia

Image of Doctors hands holding medical imaging film of multiple images of the brain

Treatment of malignant gliomas is in spite of many new approaches still disappointing. Median survival time (MST) of pts. with glioblastoma multiforme (GM) after diagnosis is 6 to 12 months. Surgery is treatment of first choice, but in most cases healing is not possible. The aims of surgery are tumor debulking or decompression of the brain. Radiation will double MST after surgery but high grade gliomas are not very radiosensitive survival. Concomitant radiation with temozollamide could increase median survival time of pts with GM from 12.1 to 14.6 months

READ THE FULL STUDY

Overall media survival graph
Prospective Phase II Trial for Recurrent High-Grade Malignant Gliomas with Capacitive Coupled Low Radiofrequency (LRF) Deep Hyperthermia 2
Dr. Sharon Gurm

Dr. Sharon Gurm

Clinic Founder & Clinical Director

Dr. Sharon Gurm is board certified in intravenous therapies, chelation therapy and has pharmaceutical prescribing authority in B.C.

Recent Posts

Naturopathic Clinic port moody health

Follow Port Moody Health